Cancer Cell
Издатель: Elsevier · ISSN 1535-6108 · 27 статей
- Toward the next generation of CAR T cell therapies for cancer
- γδ T cells modulate anti-tumor immunity in small cell lung cancer
- Ensemble learning of pathology foundation models for precision oncology
- UniCure: A multi-modal model for predicting personalized cancer therapy response
- Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis
- Intratumoral Bacillus cereus orchestrates stem-like lymphoid niches to potentiate immunotherapy response in hepatocellular carcinoma
- Proteo-genomics-guided interpretation of somatic mutations in cancer genomes
- A transient MXD4-dependent proliferative pause enables survival of brain micrometastases
- Chemotherapy enhances cancer vaccine efficacy and expands stem-like TCF1+CD8+ T cells
- Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer
- Retraction Notice to: Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity
- CPS + EG and Neo-Bioscore predict individual outcomes but not trial results after neoadjuvant therapy for early breast cancer
- Macrophage lipid signaling drives glioblastoma invasion and represents a therapeutic vulnerability
- The future of early endpoints for neoadjuvant therapy
- Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications
- Lung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab
- A sex-specific platelet switch controls anti-tumor immunity in glioblastoma
- Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype
- Spatial omics resolves adrenergic and mesenchymal cell states in neuroblastoma
- A stroma-sensing TGF-β blockade reprograms CAF-myeloid niches to induce durable tumor immunity
- Decoding neutrophil spatial heterogeneity and clinical implications in breast cancer
- Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations
- Multiomic characterization of microsatellite-stable colorectal cancer reveals distinct biology and targetable vulnerabilities
- KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer
- Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome
- Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study
- Antibiotics counteracting tumor-promoting dysbiosis in colorectal cancer